| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 514 / 669 | 23rd | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
EuroMediterranean Biomedical Journal
EuroMediterranean Biomedical Journal is Scopus-indexed (Q4, CiteScore 0.4), DOAJ. Published by Segretariato Italiano Giovani Medici - Associazione Italiana Medici.
Checked against the index lists dated .
ISSN 2279-7165Verify ISSN ↗
Publisher: Segretariato Italiano Giovani Medici - Associazione Italiana Medici
Cost to publish: Checking DOAJ for article charges…
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is EuroMediterranean Biomedical Journal indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q4, CiteScore 0.4.
What quartile is EuroMediterranean Biomedical Journal in Scopus?
EuroMediterranean Biomedical Journal is Q4 in Medicine (all) (rank 514 of 669), by CiteScore 2025.
What is the impact factor of EuroMediterranean Biomedical Journal?
EuroMediterranean Biomedical Journal is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.4, quartile Q4, 23rd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.128, quartile Q4, with an H-index of 16.
Who publishes EuroMediterranean Biomedical Journal and what is its ISSN?
EuroMediterranean Biomedical Journal is published by Segretariato Italiano Giovani Medici - Associazione Italiana Medici. Its ISSN is 2279-7165.
Is EuroMediterranean Biomedical Journal in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is EuroMediterranean Biomedical Journal open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is EuroMediterranean Biomedical Journal? — open metrics via OpenAlex
EuroMediterranean Biomedical Journal has an h-index of 11 and a 2-year mean of 1.06 citations per paper (OpenAlex). Its Scopus CiteScore is 0.4, quartile Q4. On 2-year citations it ranks #249 of 646 Scopus journals in Medicine (all).
EuroMediterranean Biomedical Journal published 119 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in EuroMediterranean Biomedical Journal? — latest 61 articles, 2026
In its latest 61 research articles (2026), authors are most often from Italy (94.3%), Iraq (1.6%) and Egypt (1.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for EuroMediterranean Biomedical Journal? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
- Author concentration94.3% of recent authorship from Italy
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.